Optimizing Initial Screening for Colorectal Cancer Detection with Adherence Behavior

Published Online:https://doi.org/10.1287/mnsc.2023.01319

References

  • Alho JM (1992) On prevalence, incidence, and duration in general stable populations. Biometrics 48(2):587–592.CrossrefGoogle Scholar
  • Allison J, Fraser C, Halloran S, Young G (2014a) Chicago 2014 5th Meeting of the Expert Working Group (EWG)—’FIT for Screening’. Accessed June 21, 2020, https://www.worldendo.org/assets-craft/pdf/committee/colorectal-cancer/fit-for-screening/weo_expert_working_group_fit_meeting_report_chicago2014.pdf.Google Scholar
  • Allison JE, Fraser CG, Halloran SP, Young GP (2014b) Population screening for colorectal cancer means getting FIT: The past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver 8(2):117–130.CrossrefGoogle Scholar
  • Anunrojwong J, Iyer K, Lingenbrink D (2023) Persuading risk-conscious agents: A geometric approach. Oper. Res. 72(1):151–166.LinkGoogle Scholar
  • Augias V, Barreto D (2020) Persuading a wishful thinker. Preprint, submitted November 27, https://arxiv.org/abs/2011.13846.Google Scholar
  • Ayer T, Alagoz O, Stout NK (2012) OR forum—A POMDP approach to personalize mammography screening decisions. Oper. Res. 60(5):1019–1034.LinkGoogle Scholar
  • Ayer T, Alagoz O, Stout NK, Burnside ES (2016) Heterogeneity in women’s adherence and its role in optimal breast cancer screening policies. Management Sci. 62(5):1339–1362.LinkGoogle Scholar
  • Ayvaci MU, Alagoz O, Burnside ES (2012) The effect of budgetary restrictions on breast cancer diagnostic decisions. Manufacturing Service Oper. Management 14(4):600–617.LinkGoogle Scholar
  • Ben-Ari E (2022) Colonoscopy after positive fit test cuts risk of colorectal cancer death. Accessed December 10, 2022, https://www.cancer.gov/news-events/cancer-currents-blog/2022/positive-fit-stool-test-colonoscopy.Google Scholar
  • Bergemann D, Brooks B, Morris S (2015) The limits of price discrimination. Amer. Econom. Rev. 105(3):921–957.CrossrefGoogle Scholar
  • Bergemann D, Brooks B, Morris S (2017) First-price auctions with general information structures: Implications for bidding and revenue. Econometrica 85(1):107–143.CrossrefGoogle Scholar
  • Bertsimas D, Kallus N (2020) From predictive to prescriptive analytics. Management Sci. 66(3):1025–1044.LinkGoogle Scholar
  • Brick JM (2013) Unit nonresponse and weighting adjustments: A critical review. J. Official Statist. 29(3):329–353.CrossrefGoogle Scholar
  • Brunnermeier MK, Parker JA (2005) Optimal expectations. Amer. Econom. Rev. 95(4):1092–1118.CrossrefGoogle Scholar
  • Bynum SA, Davis JL, Green BL, Katz RV (2012) Unwillingness to participate in colorectal cancer screening: Examining fears, attitudes, and medical mistrust in an ethnically diverse sample of adults 50 years and older. Amer. J. Health Promotion 26(5):295–300.CrossrefGoogle Scholar
  • Campbell LA, Blake JT, Kephart G, Grunfeld E, MacIntosh D (2017) Understanding the effects of competition for constrained colonoscopy services with the introduction of population-level colorectal cancer screening: A discrete event simulation model. Medical Decision Making 37(2):253–263.CrossrefGoogle Scholar
  • Caplin A, Eliaz K (2003) AIDS policy and psychology: A mechanism-design approach. RAND J. Econom. 34(4):631–646.CrossrefGoogle Scholar
  • Caplin A, Leahy J (2001) Psychological expected utility theory and anticipatory feelings. Quart. J. Econom. 116(1):55–79.CrossrefGoogle Scholar
  • Caplin A, Leahy JV (2019) Wishful thinking. NBER Working Paper No. 25707, National Bureau of Economic Research, Cambridge, MA.Google Scholar
  • Cevik M, Ayer T, Alagoz O, Sprague BL (2018) Analysis of mammography screening policies under resource constraints. Production Oper. Management 27(5):949–972.CrossrefGoogle Scholar
  • Chen LS, Liao CS, Chang SH, Lai HC, Chen THH (2007) Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16). J. Medical Screening 14(4):191–199.CrossrefGoogle Scholar
  • Chen LS, Yen AMF, Chiu SYH, Liao CS, Chen HH (2011) Baseline faecal occult blood concentration as a predictor of incident colorectal neoplasia: Longitudinal follow-up of a Taiwanese population-based colorectal cancer screening cohort. Lancet Oncology 12(6):551–558.CrossrefGoogle Scholar
  • de Clippel G, Zhang X (2022) Non-Bayesian persuasion. J. Political Econom. 130(10):2594–2642.CrossrefGoogle Scholar
  • Eeckhoudt L, Gollier C, Schlesinger H (2011) Economic and Financial Decisions Under Risk (Princeton University Press, Princeton, NJ).CrossrefGoogle Scholar
  • Eliaz K, Spiegler R (2006) Can anticipatory feelings explain anomalous choices of information sources? Games Econom. Behav. 56(1):87–104.CrossrefGoogle Scholar
  • Erenay FS, Alagoz O, Said A (2014) Optimizing colonoscopy screening for colorectal cancer prevention and surveillance. Manufacturing Service Oper. Management 16(3):381–400.LinkGoogle Scholar
  • Fraser CG, Allison JE, Halloran SP, Young GP (2012) A proposal to standardize reporting units for fecal immunochemical tests for hemoglobin. J. Natl. Cancer Inst. 104(11):810–814.CrossrefGoogle Scholar
  • Ganguly A, Tasoff J (2017) Fantasy and dread: The demand for information and the consumption utility of the future. Management Sci. 63(12):4037–4060.LinkGoogle Scholar
  • Gentzkow M, Kamenica E (2016) A Rothschild-Stiglitz approach to Bayesian persuasion. Amer. Econom. Rev. 106(5):597–601.CrossrefGoogle Scholar
  • Gentzkow M, Kamenica E (2017) Bayesian persuasion with multiple senders and rich signal spaces. Games Econom. Behav. 104:411–429.CrossrefGoogle Scholar
  • Goede SL, van Roon AH, Reijerink JC, van Vuuren AJ, Lansdorp-Vogelaar I, Habbema JDF, Kuipers EJ, van Leerdam ME, van Ballegooijen M (2013) Cost-effectiveness of one vs. two sample faecal immunochemical testing for colorectal cancer screening. Gut 62(5):727–734.CrossrefGoogle Scholar
  • Golman R, Loewenstein G (2018) Information gaps: A theory of preferences regarding the presence and absence of information. Decision 5(3):143–164.CrossrefGoogle Scholar
  • Golman R, Hagmann D, Loewenstein G (2017) Information avoidance. J. Econom. Literature 55(1):96–135.CrossrefGoogle Scholar
  • Golman R, Loewenstein G, Molnar A, Saccardo S (2022) The demand for, and avoidance of, information. Management Sci. 68(9):6454–6476.LinkGoogle Scholar
  • Grazzini G, Visioli C, Zorzi M, Ciatto S, Banovich F, Bonanomi A, Bortoli A, et al. (2009) Immunochemical faecal occult blood test: Number of samples and positivity cutoff. What is the best strategy for colorectal cancer screening? British J. Cancer 100(2):259–265.CrossrefGoogle Scholar
  • Güneş ED, Örmeci EL, Kunduzcu D (2015) Preventing and diagnosing colorectal cancer with a limited colonoscopy resource. Production Oper. Management 24(1):1–20.CrossrefGoogle Scholar
  • Hajjar A, Alagoz O (2022) Personalized disease screening decisions considering a chronic condition. Management Sci. 69(1):260–282.LinkGoogle Scholar
  • Heale W (2016) Individualised and personalised QALYs in exceptional treatment decisions. J. Medical Ethics 42(10):665–671.CrossrefGoogle Scholar
  • Helsingen LM, Kalager M (2022) Colorectal cancer screening—Approach, evidence, and future directions. NEJM Evidence 1(1):EVIDra2100035.CrossrefGoogle Scholar
  • Hernandez V, Cubiella J, Gonzalez-Mao MC, Iglesias F, Rivera C, Iglesias MB, Cid L, et al. (2014) Fecal immunochemical test accuracy in average-risk colorectal cancer screening. World J. Gastroenterology 20(4):1038–1047.CrossrefGoogle Scholar
  • Hol L, Wilschut J, van Ballegooijen M, Van Vuuren A, van der Valk H, Reijerink J, van der Togt ACM, Kuipers EJ, Habbema JDF, van Leerdam ME (2009) Screening for colorectal cancer: Random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels. British J. Cancer 100(7):1103–1110.CrossrefGoogle Scholar
  • Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, et al. (2021) SEER Cancer Statistics Review, 1975-2018. National Cancer Institute, Bethesda, MD. Accessed May 9, 2021, https://seer.cancer.gov/csr/1975_2018/.Google Scholar
  • Hubers J, Sonnenberg A, Gopal D, Weiss J, Holobyn T, Soni A (2020) Trends in wait time for colorectal cancer screening and diagnosis 2013–2016. Clinical Translational Gastroenterology 11(1):e00113.CrossrefGoogle Scholar
  • Itoh M, Takahashi K, Nishida H, Sakagami K, Okubo T (1996) Estimation of the optimal cut off point in a new immunological faecal occult blood test in a corporate colorectal cancer screening programme. J. Medical Screening 3(2):66–71.CrossrefGoogle Scholar
  • Jen HH, Hsu CY, Chen SLS, Yen AMF, Chiu SYH, Fann JCY, Lee YC, et al. (2018) Rolling-out screening volume affecting compliance rate and waiting time of FIT-based colonoscopy. J. Clinical Gastroenterology 52(9):821–827.CrossrefGoogle Scholar
  • Kamenica E, Gentzkow M (2011) Bayesian persuasion. Amer. Econom. Rev. 101(6):2590–2615.CrossrefGoogle Scholar
  • Karlsson N, Loewenstein G, Seppi D (2009) The ostrich effect: Selective attention to information. J. Risk Uncertainty 38(2):95–115.CrossrefGoogle Scholar
  • Kőszegi B (2003) Health anxiety and patient behavior. J. Health Econom. 22(6):1073–1084.CrossrefGoogle Scholar
  • Kőszegi B, Rabin M (2007) Reference-dependent risk attitudes. Amer. Econom. Rev. 97(4):1047–1073.CrossrefGoogle Scholar
  • Kruse GR, Khan SM, Zaslavsky AM, Ayanian JZ, Sequist TD (2015) Overuse of colonoscopy for colorectal cancer screening and surveillance. J. General Internal Medicine 30(3):277–283.CrossrefGoogle Scholar
  • Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM (2001) Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer: A cost-effectiveness analysis. Ann. Internal Medicine 135(9):769–781.CrossrefGoogle Scholar
  • Lee SY, Lee EE (2018) Cancer screening in Koreans: A focus group approach. BMC Public Health 18(1):1–12.CrossrefGoogle Scholar
  • Li J, Dong M, Ren Y, Yin K (2015) How patient compliance impacts the recommendations for colorectal cancer screening. J. Combin. Optim. 30(4):920–937.CrossrefGoogle Scholar
  • Li Y, Meng J, Song C, Zheng K (2020) Information avoidance and medical screening: A field experiment in China. Management Sci. 67(7):4252–4272.LinkGoogle Scholar
  • Lim TZ, Lau J, Wong GJ, Tan LYT, Chang YJ, Natarajan K, Yi H, Wong ML, Tan KK (2021) Factors predicting improved compliance toward colonoscopy in individuals with positive faecal immunochemical test (FIT). Cancer Med. 10(21):7735–7746.CrossrefGoogle Scholar
  • Lingenbrink D, Iyer K (2019) Optimal signaling mechanisms in unobservable queues. Oper. Res. 67(5):1397–1416.LinkGoogle Scholar
  • Ministry of Health Singapore (2020a) Cost of a colonoscopy. Accessed March 3, 2021, https://www.moh.gov.sg/cost-financing/fee-benchmarks-and-bill-amount-information/.Google Scholar
  • Ministry of Health Singapore (2020b) Definition of average risk. Accessed November 15, 2020, https://www.healthhub.sg/live-healthy/106/screening_colorectal_cancer_nuhs.Google Scholar
  • Ministry of Health Singapore (2022) Average waiting time for cancer screening in public hospitals. Accessed May 9, 2022, https://www.moh.gov.sg/news-highlights/details/average-waiting-time-for-cancer-screening-in-public-hospitals.Google Scholar
  • Ministry of Health Singapore (2023) Healthier you, with Healthier SG. Accessed February 27, 2023, https://www.healthiersg.gov.sg/.Google Scholar
  • Mundru N (2019) Predictive and prescriptive methods in operations research and machine learning: An optimization approach. PhD thesis, Massachusetts Institute of Technology, Cambridge.Google Scholar
  • Murphy CC, Sandler RS, Grubber JM, Johnson MR, Fisher DA (2016) Underuse and overuse of colonoscopy for repeat screening and surveillance in the Veterans Health Administration. Clinical Gastroenterology Hepatology 14(3):436–444.CrossrefGoogle Scholar
  • National Registry of Diseases Office (2017) Singapore Cancer Registry annual registry report 2015. Accessed May 10, 2020, https://www.nrdo.gov.sg/docs/librariesprovider3/Publications-Cancer/cancer-registry-annual-report-2015_web.pdf?sfvrsn=10.Google Scholar
  • National University Hospital (2023) Colorectal cancer. Accessed January 25, 2023, https://www.nuh.com.sg/health-resources/diseases-and-conditions/colorectal-cancer.Google Scholar
  • Navarro M, Nicolas A, Ferrandez A, Lanas A (2017) Colorectal cancer population screening programs worldwide in 2016: An update. World J. Gastroenterology 23(20):3632–3642.CrossrefGoogle Scholar
  • Oster E, Shoulson I, Dorsey E (2013) Optimal expectations and limited medical testing: Evidence from Huntington disease. Amer. Econom. Rev. 103(2):804–830.CrossrefGoogle Scholar
  • Patel SS, Kilgore ML (2015) Cost effectiveness of colorectal cancer screening strategies. Cancer Control 22(2):248–258.CrossrefGoogle Scholar
  • Pellat A, Deyra J, Coriat R, Chaussade S (2018) Results of the national organised colorectal cancer screening program with FIT in Paris. Sci. Rep. 8(1):4162.CrossrefGoogle Scholar
  • Peng SM, Chiu HM, Jen HH, Hsu CY, Chen SLS, Chiu SYH, Yen AMF, Fann JCY, Lee YC, Chen HH (2019) Quantile-based fecal hemoglobin concentration for assessing colorectal neoplasms with 1,263,717 Taiwanese screenees. BMC Medical Informatics Decision Making 19(1):1–10.CrossrefGoogle Scholar
  • Pliskin JS, Shepard DS, Weinstein MC (1980) Utility functions for life years and health status. Oper. Res. 28(1):206–224.LinkGoogle Scholar
  • Plumb AA, Ghanouni A, Rainbow S, Djedovic N, Marshall S, Stein J, Taylor SA, Halligan S, Lyratzopoulos G, von Wagner C (2017) Patient factors associated with non-attendance at colonoscopy after a positive screening faecal occult blood test. J. Medical Screening 24(1):12–19.CrossrefGoogle Scholar
  • Robertson DJ, Lee JK, Boland CR, Dominitz JA, Giardiello FM, Johnson DA, Kaltenbach T, Lieberman D, Levin TR, Rex DK (2017) Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology 152(5):1217–1237.CrossrefGoogle Scholar
  • Roesler AK, Szentes B (2017) Buyer-optimal learning and monopoly pricing. Amer. Econom. Rev. 107(7):2072–2080.CrossrefGoogle Scholar
  • Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology (Lippincott Williams & Wilkins, Philadelphia).Google Scholar
  • Schneider JL, Rivelli JS, Gruss I, Petrik AF, Nielson CM, Green BB, Coronado GD (2020) Barriers and facilitators to timely colonoscopy completion for safety net clinic patients. Amer. J. Health Behav. 44(4):460–472.CrossrefGoogle Scholar
  • Schweizer N, Szech N (2018) Optimal revelation of life-changing information. Management Sci. 64(11):5250–5262.LinkGoogle Scholar
  • Shih HC, Chou P, Liu CM, Tung TH (2007) Estimation of progression of multi-state chronic disease using the Markov model and prevalence pool concept. BMC Medical Informatics Decision Making 7(1):1–12.CrossrefGoogle Scholar
  • Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J. Clinicians 73(1):17–48.CrossrefGoogle Scholar
  • Singapore Department of Statistics (2018) Singapore population trends 2018. Accessed April 13, 2021, https://www.singstat.gov.sg/-/media/files/publications/population/population2018.pdf.Google Scholar
  • Singapore Health Hub (2011) Screen for life. Accessed November 14, 2020, https://www.healthhub.sg/programmes/61/Screen_for_Life.Google Scholar
  • Singapore Manpower Research and Statistics Department (2018) Labour force in Singapore, 2018. Accessed September 25, 2019, https://stats.mom.gov.sg/iMAS_PdfLibrary/mrsd-Labour-Force-in-Singapore-Advance-Release-2018.pdf.Google Scholar
  • Song LL, Li YM (2016) Current noninvasive tests for colorectal cancer screening: An overview of colorectal cancer screening tests. World J. Gastroenterology Oncology 8(11):793–800.Google Scholar
  • Sonnenberg A, Delco F, Inadomi JM (2000) Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann. Internal Medicine 133(8):573–584.CrossrefGoogle Scholar
  • Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clinicians 71(3):209–249.CrossrefGoogle Scholar
  • Tan WS, Tang CL, Koo WH (2013) Opportunistic screening for colorectal neoplasia in Singapore using faecal immunochemical occult blood test. Singapore Medical J. 54(4):220–223.CrossrefGoogle Scholar
  • Telford JJ, Levy AR, Sambrook JC, Zou D, Enns RA (2010) The cost-effectiveness of screening for colorectal cancer. Canadian Medical Assoc. J. 182(12):1307–1313.CrossrefGoogle Scholar
  • Toes-Zoutendijk E, Kooyker AI, Dekker E, Spaander MC, Opstal-van Winden AW, Ramakers C, Buskermolen M, et al. (2020) Incidence of interval colorectal cancer after negative results from first-round fecal immunochemical screening tests, by cutoff value and participant sex and age. Clinical Gastroenterology Hepatology 18(7):1493–1500.CrossrefGoogle Scholar
  • Vaithianathan R, Hool B, Hurd MD, Rohwedder S (2021) High-frequency Internet survey of a probability sample of older Singaporeans: The Singapore life panel. Singapore Econom. Rev. 66(06):1759–1778.CrossrefGoogle Scholar
  • van Roon AH, Wilschut JA, Hol L, van Ballegooijen M, Reijerink JC, ‘t Mannetje H, Kranenburg LJC, et al. (2011) Diagnostic yield improves with collection of 2 samples in fecal immunochemical test screening without affecting attendance. Clinical Gastroenterology Hepatology 9(4):333–339.CrossrefGoogle Scholar
  • Weinstein MC, Torrance G, McGuire A (2009) QALYs: The basics. Value Health 12(Suppl. 1)S5–S9.CrossrefGoogle Scholar
  • Wilschut JA, Hol L, Dekker E, Jansen JB, Van Leerdam ME, Lansdorp-Vogelaar I, Kuipers EJ, Habbema JDF, Van Ballegooijen M (2011) Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology 141(5):1648–1655.CrossrefGoogle Scholar
  • World Health Organization (2022) Cancer. Accessed Jan 10, 2022, https://www.who.int/health-topics/cancer#tab=tab_3.Google Scholar
  • Xiang J (2024) Physicians as persuaders: Evidence from hospitals in China. Working paper, Pennsylvania State University, University Park.Google Scholar
  • Yamaji Y, Mitsushima T, Ikuma H, Watabe H, Okamoto M, Kawabe T, Wada R, Doi H, Omata M (2004) Incidence and recurrence rates of colorectal adenomas estimated by annually repeated colonoscopies on asymptomatic Japanese. Gut 53(4):568–572.CrossrefGoogle Scholar
  • Yu D, Hopman WM, Paterson WG (2008) Wait time for endoscopic evaluation at a Canadian tertiary care centre: Comparison with Canadian Association of Gastroenterology targets. Canadian J. Gastroenterology 22(7):621–626.CrossrefGoogle Scholar
  • Zhang Z, Denton BT, Morgan TM (2022) Optimization of active surveillance strategies for heterogeneous patients with prostate cancer. Production Oper. Management 31(11):4021–4037.CrossrefGoogle Scholar
  • Zhang J, Denton BT, Balasubramanian H, Shah ND, Inman BA (2012) Optimization of prostate biopsy referral decisions. Manufacturing Service Oper. Management 14(4):529–547.LinkGoogle Scholar
INFORMS site uses cookies to store information on your computer. Some are essential to make our site work; Others help us improve the user experience. By using this site, you consent to the placement of these cookies. Please read our Privacy Statement to learn more.